Evaluation of the lymphoproliferation of mononuclear cells in cutaneous leishmaniasis patients treated with Libidibia ferrea
- 30 September 2021
- journal article
- research article
- Published by Acta Brasiliensis in Acta Brasiliensis
- Vol. 5 (3), 97-102
- https://doi.org/10.22571/2526-4338560
Abstract
American integumentary leishmaniasis (ATL) is a neglected disease that mostly affects vulnerable populations. Its broad spectrum of clinical manifestations is related to the type of immune response produced by the host and the species of Leishmania involved. In recent years, the use of medicinal plants has become a therapeutic alternative in the treatment of infectious parasitic diseases. This research aimed to evaluate the lymphoproliferative responses of peripheral blood mononuclear cells (PBMCs) of patients with cutaneous leishmaniasis (CL) before and after treatment, and healthy individuals. The lymphoproliferative response was evaluated in cell culture using stimuli of the dichloromethane fraction (DCM) obtained from Libidibia ferrea, Glucantime® and phytohemagglutinin - PHA using a BrdU Cell Proliferation after 72 h of incubation. In cultures treated with the DCM fraction, intense induction of lymphoproliferation was observed (p<0.0001), as was also observed in response to the PHA mitogen, and there was a significant difference when compared with the conventional treatment (p<0.0135). In the post-treatment and healthy groups, although the compound induced lymphoproliferation, there was no statistical difference. These results suggest that the organic compound played an important inducing role in lymphoproliferation, which highlights the importance of continuity involving new studies in order to evaluate its immunomodulatory activity.Keywords
This publication has 13 references indexed in Scilit:
- American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short‐term possibilities for an alternative treatmentTropical Medicine & International Health, 2019
- Antileishmanial activity of extracts from Libidibia ferrea: development of in vitro and in vivo testsActa Amazonica, 2017
- New human case reports of cutaneous leishmaniasis by Leishmania (Viannia) naiffi in the Amazon region, BrazilActa Amazonica, 2017
- Assessment of the healing activity of jucá pods [Libidibia ferrea (Mart. ex Tul.) L. P. Queiroz] in cutaneous lesions of ratsActa Scientiarum. Technology, 2016
- The Role of Inflammatory, Anti-Inflammatory, and Regulatory Cytokines in Patients Infected with Cutaneous Leishmaniasis in Amazonas State, BrazilJournal of Immunology Research, 2014
- Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cureCellular Immunology, 2012
- Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatmentJournal of Clinical Laboratory Analysis, 2009
- Anti-leishmanial and immunomodulatory activities of extracts from Portulaca hirsutissima and Portulaca werdermanniiFitoterapia, 2007
- Chemokines in host–parasiteinteractions in leishmaniasisTrends in Parasitology, 2006
- Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis PatientsInfection and Immunity, 2002